Drug Declaration

FCC ID: Q639560

Attestation Statements

Download: PDF
FCCID_2230336

~*:—iridium Everywhere LETTER OF Agaency 16 January 2014 TRaC Global Ltd. 100 Frobisher Business Park Malvern Worcestershire WR14 1BX UK To Whom It May Concern: We certify that we are not subject to denial of federal benefits, that includes FCC benefits, pursuant to Section 5301 of the Anti—Drug Abuse ACT of 1988, U.S.C. 862. Further, no party, as defined in 47 CFR 1.2002(b), to the application, is subject to denial of federal benefits, that includes FCC benefits. Thank you for your attention to this matter. 7,nna Bethea—Murphy VP Regulatory Engineering Iridium Communications Inc. Tel: +1 703 287 7404 Fax: +1 703 287 7450 Email: donna.bethea—murphy@iridium.com 1750 Tysons Boulevard, Suite 1400 | McLean, VA | 22102 USA tel: +1.703.287.7400 | fax: +1.703.287.7450 www.iridium.com


Document Created: 2014-01-16 15:34:20
Document Modified: 2014-01-16 15:34:20
© 2024 FCC.report
This site is not affiliated with or endorsed by the FCC